[Effect of miR-155-5p regulating the TLR4/MAPK/NF-κB pathway on inflammatory response, coronary artery lesion and immune function in mice with Kawasaki disease]. [PDF]
Liu WD, Jiang FZ, Zhu DX, Liang YY.
europepmc +1 more source
[Eurycomanone inhibits renal ischemia/reperfusion-induced mitochondrial dysfunction and inflammation in mice by binding to STAT3 to inhibit its phosphorylation]. [PDF]
Liu Z +8 more
europepmc +1 more source
[Chinese medicine Gandouling attenuates brain injury in hepatolenticular degeneration mice by inhibiting ferroptosis via the SIRT1/FoxO3 signaling pathway]. [PDF]
Wu K +5 more
europepmc +1 more source
[Expert consensus on monoclonal antibody immunoprophylaxis against respiratory syncytial virus in infants and young children in tropical and subtropical regions of China]. [PDF]
Subspecialty Group of Neonatology +4 more
europepmc +1 more source
[Impact of HIF-1α-expressing Cellular Subpopulations on Lymph Node Metastasis and Postoperative Recurrence in Non-small Cell Lung Cancer]. [PDF]
Cao F +5 more
europepmc +1 more source
[Efficacy of Ganciclovir Combined With Recombinant Human Interferon α-1b for Viral Encephalitis in Children]. [PDF]
Han B, Zhao L, Han X, Kong N, Qin X.
europepmc +1 more source
[Preparation of magnetic bifunctional materials for exosome capture from serum and phosphopeptide enrichment]. [PDF]
Wang ZR, Zheng HJ, Jia Q.
europepmc +1 more source
[Multi-omics integration deciphers immune-metabolic heterogeneity in colorectal cancer: a prognostic model and therapeutic strategies targeting ANGPTL4/FABP4/RBP7]. [PDF]
Ding N +9 more
europepmc +1 more source
[Interpretation of the 2025 Asian Federation of Osteoporosis Societies (AFOS) Clinical Consensus: Atypical femoral fractures in patients with osteoporosis]. [PDF]
Xie M, Kong Q.
europepmc +1 more source
[Determination of 22 organophosphates and their metabolites and 11 phthalate metabolites in human whole blood by ultra performance liquid chromatography-tandem mass spectrometry]. [PDF]
Shi FY, Xu HY, Li JH, Xu MY.
europepmc +1 more source

